Bullish option flow detected in Crispr Therapeutics with 5,524 calls trading, 2x expected, and implied vol increasing over 1 point to 72.75%. Apr-24 67.5 puts and Apr-24 105 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.40. Earnings are expected on May 6th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CRSP:
- CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Crispr Therapeutics reports Q4 EPS $1.10, consensus (7c)
- Crispr Therapeutics options imply 7.2% move in share price post-earnings
- CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit
- Crispr Therapeutics initiated with a Peer Perform at Wolfe Research
